A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Studies Continue on COVID-19 Vaccines in Children Younger Than 12


With children ages 12 to 17 now eligible for COVID-19 vaccination, many families have jumped at the chance to protect their older kids from SARS-CoV-2 infection. However, what about children younger than 12? Pfizer is now starting another large scale study of the safety and efficacy of its COVID-19 immunization among kids ages 6 months to 11 years old. The study will include 4,500 children in the United States, Finland, Poland, and Spain. Study participants ages 5 to 11 will receive 10 micrograms of the vaccine and those ages 6 months to 5 years will receive 3 micrograms. The dose for those ages 12 and older is 30 micrograms. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy